Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials

Overview of attention for article published in Respiratory Research, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
policy: 1 policy source

twitter: 3 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 67 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Biologic Drugs for Severe Asthma

Cited by Canadian Agency for Drugs and Technologies in Health on 30 Jan 2024

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Biologic Drugs for Severe Asthma

Cited by Canadian Agency for Drugs and Technologies in Health on 25 Oct 2023

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.